TrialJournal of clinical pharmacology2025

Exposure-Response Analysis of Tofacitinib in Active Psoriatic Arthritis: Results from Two Phase 3 Studies.

Sujatha Menon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.